ARTICLE | Clinical News
Biocompatibles stent data
February 1, 2000 8:00 AM UTC
Biocompatibles (LSE:BII) said that the DISTINCT study of its BiodivYsio phosphorylcholine-coated stent met its end points of showing equivalence to a marketed stent. The company has submitted two of t...